v3.26.3
STOCK BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Changes in Company's Nonvested Restricted Stock Units
A summary of changes in the Company’s nonvested Restricted Stock Units (“RSUs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2026 were as follows:
Nonvested RSUsSharesWeighted-Average
Grant-Date
Fair Value
Nonvested at January 1, 2026198,757 $59.96 
Granted79,772 67.59 
Vested(73,702)63.63 
Forfeited(20,287)59.96 
Nonvested at September 30, 2026184,540 $61.79 
Schedule of Changes in Company's Nonvested Performance Stock Units
A summary of changes in the Company’s nonvested Market Based Performance Stock Units (“Market Based PSUs”) under the Omnibus Incentive Plan for the nine months ended September 30, 2026 were as follows:
Nonvested Market Based PSUsSharesWeighted-Average
Grant-Date
Fair Value
Nonvested at January 1, 2026245,423 $93.82 
Granted90,689 121.27 
Performance adjustment(22,452)— 
Vested(49,855)81.95 
Forfeited(16,296)108.61 
Nonvested at September 30, 2026247,509 $107.48 
Schedule of Fair Value of Market Based Performance Stock Units, Weighted Average Assumptions
The fair value of the Market Based PSUs granted was determined using the following weighted-average assumptions:
Nine Months Ended September 30,
20262025
Grant dateMay 1, 2026May 1, 2025
Performance period3.00 years3.00 years
Stock price$67.55 $54.38 
Triumph Financial stock price volatility42.48 %42.22 %
Risk-free rate3.84 %3.62 %
Schedule of Changes in Company's Stock Options
A summary of the changes in the Company’s stock options under the Omnibus Incentive Plan for the nine months ended September 30, 2026 were as follows:
Stock OptionsSharesWeighted-Average
Exercise Price		Weighted-Average
Remaining
Contractual Term
(In Years)		Aggregate
Intrinsic Value
(In Thousands)
Outstanding at January 1, 2026328,197 $50.73 
Granted68,894 67.55 
Exercised(33,293)26.85 
Forfeited(9,979)61.43 
Expired— — 
Outstanding at September 30, 2026353,819 $55.95 6.49$3,109 
Fully vested shares and shares expected to vest at September 30, 2026353,819 $55.95 6.49$3,109 
Shares exercisable at September 30, 2026193,427 $51.26 4.63$2,644 
Schedule of Information Related to Stock Options
Information related to the stock options for the nine months ended September 30, 2026 and 2025 was as follows:
Nine Months Ended September 30,
(Dollars in thousands, except per share amounts)20262025
Aggregate intrinsic value of options exercised$1,191 $214 
Cash received from option exercises, net301 218 
Tax benefit realized from option exercises250 45 
Weighted average fair value per share of options granted$36.42 $28.35 
Schedule of Fair Value of Stock Options Granted Weighted-Average Assumptions
The fair value of the stock options granted was determined using the following weighted-average assumptions:
Nine Months Ended September 30,
20262025
Risk-free interest rate4.07 %3.88 %
Expected term6.25 years6.25 years
Expected stock price volatility50.55 %48.48 %
Dividend yield— —